Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer [Phase 2]
A Phase 2 clinical trial evaluating Ubamatamab in combination therapy for adults with platinum-resistant ovarian cancer; recruitment is ongo…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors [Phase 1]
This clinical trial update reports a Phase 1 dose-determining study of EXS74539 (REC-4539) in participants with select solid tumors, current…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Adapted Helping Ovarian Cancer Patients Cope Intervention to Address Burnout for Gynecologic Oncology Clinicians [NA]
This clinical trial aims to adapt an intervention to help ovarian cancer patients cope and to address burnout among gynecologic oncology cli…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Study to Assess the Efficacy and Safety of Rina-S Plus Standard of Care Compared to Standard of Care for Maintenance Treatment of Participants With Recurrent Platinum-sensitive Ovarian Cancer After Second-line (2L) Platinum-based Doublet Chemotherapy [Phase 3]
A Phase 3 trial comparing Rina-S plus standard of care versus standard of care for maintenance therapy in recurrent platinum-sensitive ovari…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Primary Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy (HIPEC) [Phase 3]
Phase 3 study evaluating primary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC) for ovarian cancer;…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer [Phase 1]
A Phase 1 clinical trial evaluating Azenosertib (ZN-c3) in patients with epithelial ovarian cancer and other solid tumors is currently recru…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors [Phase 1]
Phase I study of SYS6043 in patients with advanced or metastatic solid tumors is currently recruiting, including prostate cancer, small cell…
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast Cancer [Phase 3]
A Phase 3 study evaluating romiplostim for chemotherapy-induced thrombocytopenia in adults with non-small cell lung cancer, ovarian cancer, …
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS) [Phase 1]
Phase 1 study of ADP-A2M4CD8 as monotherapy or in combination with nivolumab or pembrolizumab in HLA-A2+ patients with MAGE-A4-positive tumo…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Multidimensional Burden of Platinum Resistant Ovarian Cancer (PROC) on Patients and Caregivers in Canada
A clinical trial update indicates the study on the multidimensional burden of platinum-resistant ovarian cancer on patients and caregivers i…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Intensification Treatment of Ovarian Cancer by PIPAC [Phase 2]
An ongoing Phase 2 trial from Moscow evaluating intensified treatment of advanced epithelial ovarian cancer using PIPAC (pressurized intrape…
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2 [Phase 2]
Update on a Phase 2 study of disitamab vedotin in HER2-expressing solid tumors, currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors [Phase 1]
FT836 is being studied in a Phase 1 trial for advanced solid tumors, administered with or without chemotherapy and/or monoclonal antibodies.…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Germline Alterations of Tumor Susceptibility Genes in New York Cancer Patients [NA]
This clinical trial update reports on germline alterations of tumor susceptibility genes in New York cancer patients across multiple cancer …
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: Trial Comparing Simple Follow-up to Exploratory Laparotomy Plus "in Principle" (Hyperthermic Intraperitoneal Chemotherapy) HIPEC in Colorectal Patients [Phase 3]
Phase 3 trial comparing simple follow-up to exploratory laparotomy plus HIPEC in colorectal cancer patients with limited peritoneal metastas…
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: A Study of STRO-002 in Chinese Adults With Epithelial Ovarian Cancer and Other Advanced Malignant Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating STRO-002 in Chinese adults with epithelial ovarian cancer and other advanced malignant solid tumors ha…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: A Study of MOv18 IgE in Patients With Solid Tumours That Express Folate Receptor Alpha [Phase 1]
Phase 1 study of MOv18 IgE in solid tumors expressing folate receptor alpha is currently recruiting, evaluating safety and early signals of …
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies [Phase 2]
This Phase 2 trial investigates changes in disease activity and safety in adults with gynecologic cancers treated with IMGN151, either alone…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Oregovomab in Combination With Bevacizumab Plus Chemo in BRCA Wild Type Platinum Sensitive Recurrent Ovarian Cancer [Phase 1, Phase 2]
A Phase 1/2 study evaluating oregovomab in combination with bevacizumab and chemotherapy for BRCA wild-type platinum-sensitive recurrent ova…
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers [Phase 1, Phase 2]
This clinical trial update describes a CD70-targeted CAR-T cell therapy using patients' peripheral blood lymphocytes to treat CD70-expressin…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention [NA]
A clinical study enrolling high-risk women to assess the safety of delaying oophorectomy after tubectomy as a preventive strategy against ov…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Vaccine Therapy Plus Pembrolizumab in Treating Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer [Phase 1, Phase 2]
A phase 1/2 clinical trial is evaluating a cancer vaccine therapy in combination with pembrolizumab for advanced fallopian tube, primary per…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction With a Vaccine Directed Against These Antigens in Participants With Metastatic Cancer [Phase 1]
Phase 1 clinical trial evaluating autologous T-cells engineered to target KRAS mutations in combination with a KRAS-directed vaccine for met…
-
CLINICAL_TRIALS trial_result · 2026-04-03Clinical Trial Update: Pembrolizumab in Treating Participants With Metastatic, Recurrent or Locally Advanced Cancer and Genomic Instability [Phase 2]
Phase 2 trial evaluating pembrolizumab in patients with metastatic, recurrent, or locally advanced cancers associated with BRCA1/BRCA2, POLD…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: A Clinical Study Evaluating a Combination of Oregovomab and Niraparib in Adult Women With Platinum Sensitive Recurrent Ovarian Cancer. [Phase 2]
Clinical trial update for a Phase 2 study evaluating a combination of oregovomab and niraparib in platinum-sensitive recurrent ovarian cance…